Division of Ophthalmology, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Acta Ophthalmol. 2019 Jun;97(4):e641-e647. doi: 10.1111/aos.13963. Epub 2018 Oct 17.
Ocular manifestations of syphilis have been reported in 2-10% of systemic infection. The purpose of this study was to report the incidence of ocular syphilis and various ocular manifestations, particularly optic nerve involvement, in newly diagnosed cases.
This was a retrospective study. Medical records of newly diagnosed syphilis patients between January 2009 and January 2017 in a tertiary medical centre were reviewed.
There were 123 new systemic syphilis cases out of 569,222 (0.02%) admissions to the Tel Aviv Medical Center during the study period. Ninety-three of the 123 patients (76%) underwent ophthalmological examination. Twenty-three of the 93 patients (25%, mean age 48.6 ± 12.9 years, 20 males) had ocular syphilis, and in 12/23 (52%) patients, the ocular symptoms and findings prompted syphilis investigation. Eighteen of the 23 (78%) had optic nerve involvement, and the most common was inflammatory disc oedema. Older age (p = 0.0005) and tertiary stage disease (p = 0.0441) were associated with ocular manifestations and the presence of optic nerve findings. Human immunodeficiency virus (HIV) was associated with ocular but not optic nerve findings. Treatment included intravenous penicillin G, and four patients with severe optic neuropathy were also treated with systemic corticosteroids. Visual acuity significantly improved in most patients (p < 0.05).
Ocular syphilis was found in one-quarter of the patients diagnosed with systemic syphilis and preceded the diagnosis of systemic disease in one-half of them. Optic nerve involvement was a common manifestation. A high index of suspicion for Treponema infection is required in patients presenting with optic nerve involvement to facilitate prompt diagnosis and treatment. Post-treatment visual outcome was good.
梅毒的眼部表现已在 2-10%的全身感染中报告。本研究的目的是报告新诊断的梅毒患者眼部梅毒的发生率和各种眼部表现,特别是视神经受累。
这是一项回顾性研究。回顾了 2009 年 1 月至 2017 年 1 月期间在特拉维夫医疗中心新诊断的梅毒患者的病历。
在研究期间,共有 569222 例住院患者中有 123 例新的全身梅毒病例(0.02%)。在 123 例患者中,有 93 例(76%)接受了眼科检查。在这 93 例患者中,有 23 例(25%,平均年龄 48.6±12.9 岁,男性 20 例)患有眼部梅毒,在 12/23 例(52%)患者中,眼部症状和发现提示梅毒检查。23 例中的 18 例(78%)有视神经受累,最常见的是炎症性视盘水肿。年龄较大(p=0.0005)和三期疾病(p=0.0441)与眼部表现和视神经表现有关。人类免疫缺陷病毒(HIV)与眼部而非视神经表现有关。治疗包括静脉注射青霉素 G,4 例严重视神经病变患者还接受了全身皮质类固醇治疗。大多数患者的视力显著改善(p<0.05)。
在诊断为全身梅毒的患者中,有四分之一发现了眼部梅毒,其中一半在全身疾病诊断之前就已出现眼部梅毒。视神经受累是常见的表现。对于出现视神经受累的患者,需要高度怀疑梅毒感染,以促进及时诊断和治疗。治疗后的视力预后良好。